BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7541648)

  • 1. Frequent loss of chromosome arm 1p DNA in parathyroid adenomas.
    Cryns VL; Yi SM; Tahara H; Gaz RD; Arnold A
    Genes Chromosomes Cancer; 1995 May; 13(1):9-17. PubMed ID: 7541648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic localization of novel candidate tumor suppressor gene loci in human parathyroid adenomas.
    Tahara H; Smith AP; Gas RD; Cryns VL; Arnold A
    Cancer Res; 1996 Feb; 56(3):599-605. PubMed ID: 8564978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parathyroid tumor suppressor on 1p: analysis of the p18 cyclin-dependent kinase inhibitor gene as a candidate.
    Tahara H; Smith AP; Gaz RD; Zariwala M; Xiong Y; Arnold A
    J Bone Miner Res; 1997 Sep; 12(9):1330-4. PubMed ID: 9286748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Putative parathyroid tumor suppressor on 1p: independent molecular mechanisms of tumorigenesis from 11q allelic loss.
    Imanishi Y; Tahara H
    Am J Kidney Dis; 2001 Oct; 38(4 Suppl 1):S165-7. PubMed ID: 11576946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of heterozygosity in sporadic parathyroid tumours: involvement of chromosome 1 and the MEN1 gene locus in 11q13.
    Dwight T; Twigg S; Delbridge L; Wong FK; Farnebo F; Richardson AL; Nelson A; Zedenius J; Philips J; Larsson C; Teh BT; Robinson B
    Clin Endocrinol (Oxf); 2000 Jul; 53(1):85-92. PubMed ID: 10931084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel chromosomal abnormalities identified by comparative genomic hybridization in parathyroid adenomas.
    Palanisamy N; Imanishi Y; Rao PH; Tahara H; Chaganti RS; Arnold A
    J Clin Endocrinol Metab; 1998 May; 83(5):1766-70. PubMed ID: 9589690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct target regions for chromosome 1p deletions in parathyroid adenomas and carcinomas.
    Välimäki S; Forsberg L; Farnebo LO; Larsson C
    Int J Oncol; 2002 Oct; 21(4):727-35. PubMed ID: 12239610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular pathogenesis of primary hyperparathyroidism.
    Arnold A; Shattuck TM; Mallya SM; Krebs LJ; Costa J; Gallagher J; Wild Y; Saucier K
    J Bone Miner Res; 2002 Nov; 17 Suppl 2():N30-6. PubMed ID: 12412775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the RAD54 gene on chromosome 1p as a potential tumor-suppressor gene in parathyroid adenomas.
    Carling T; Imanishi Y; Gaz RD; Arnold A
    Int J Cancer; 1999 Sep; 83(1):80-2. PubMed ID: 10449612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletion of 11q23 and cyclin D1 overexpression are frequent aberrations in parathyroid adenomas.
    Hemmer S; Wasenius VM; Haglund C; Zhu Y; Knuutila S; Franssila K; Joensuu H
    Am J Pathol; 2001 Apr; 158(4):1355-62. PubMed ID: 11290553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of chromosome arm 9p DNA and analysis of the p16 and p15 cyclin-dependent kinase inhibitor genes in human parathyroid adenomas.
    Tahara H; Smith AP; Gaz RD; Arnold A
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3663-7. PubMed ID: 8855819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclin D1/PRAD1 expression in parathyroid adenomas: an immunohistochemical study.
    Hsi ED; Zukerberg LR; Yang WI; Arnold A
    J Clin Endocrinol Metab; 1996 May; 81(5):1736-9. PubMed ID: 8626826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PRAD1/cyclin D1 proto-oncogene: genomic organization, 5' DNA sequence, and sequence of a tumor-specific rearrangement breakpoint.
    Motokura T; Arnold A
    Genes Chromosomes Cancer; 1993 Jun; 7(2):89-95. PubMed ID: 7687458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent loss of heterozygosity at 1p36.3 and p73 abnormality in parathyroid adenomas.
    Shan L; Yang Q; Nakamura Y; Nakamura M; Miyauchi A; Tsujimoto M; Nakatani Y; Wakasa K; Mori I; Kakudo K
    Mod Pathol; 2001 Apr; 14(4):273-8. PubMed ID: 11301342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential loss of heterozygosity in familial, sporadic, and uremic hyperparathyroidism.
    Farnebo F; Teh BT; Dotzenrath C; Wassif WS; Svensson A; White I; Betz R; Goretzki P; Sandelin K; Farnebo LO; Larsson C
    Hum Genet; 1997 Mar; 99(3):342-9. PubMed ID: 9050920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A possible tumor suppressor gene for parathyroid adenomas.
    Iwasaki H
    Int Surg; 1996; 81(1):71-6. PubMed ID: 8803711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cyclin D1/PRAD1 oncogene in human neoplasia.
    Arnold A
    J Investig Med; 1995 Dec; 43(6):543-9. PubMed ID: 8605613
    [No Abstract]   [Full Text] [Related]  

  • 18. p53 abnormalities in human parathyroid carcinoma.
    Cryns VL; Rubio MP; Thor AD; Louis DN; Arnold A
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1320-4. PubMed ID: 8200932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletion mapping of chromosomal region 1p32-pter in primary breast cancer.
    Bièche I; Khodja A; Lidereau R
    Genes Chromosomes Cancer; 1999 Mar; 24(3):255-63. PubMed ID: 10451706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of cyclin D1/PRAD1 point mutations in human breast cancers and parathyroid adenomas and identification of a new cyclin D1 gene polymorphism.
    Hosokawa Y; Tu T; Tahara H; Smith AP; Arnold A
    Cancer Lett; 1995 Jul; 93(2):165-70. PubMed ID: 7621424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.